Interstitial lung disease in scleroderma
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 29 (2) , 371-390
- https://doi.org/10.1016/s0889-857x(03)00025-5
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to sclerodermaArthritis & Rheumatism, 2002
- Esophageal involvement and pulmonary manifestations in systemic sclerosisArthritis & Rheumatism, 2001
- Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lungThorax, 2001
- Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin diseaseAnnals of the Rheumatic Diseases, 2001
- Extensive Surface Phenotyping of Alveolar Macrophages in Interstitial Lung DiseaseClinical Immunology, 2000
- A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1999
- Immunohistochemical localization of transforming growth factor‐β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disordersHistopathology, 1994
- 67Gallium lung scans in progressive systemic sclerosisArthritis & Rheumatism, 1983
- Serological markers in progressive systemic sclerosis: clinical correlations.Annals of the Rheumatic Diseases, 1983
- Abnormalities of Pulmonary Vascular Dynamics and Inflammation In Early Progressive Systemic SclerosisArthritis & Rheumatism, 1981